Vaginal trichomoniasis is one of the very common gynecologic clinical entities; and yet, in spite of numerous American and European publications in the last one and one-half decades, controversies continue unabated, especially on the subject of therapy. There are considerable differences also in the criteria employed to diagnose cures. Today the drastic scrubbing procedures have been almost replaced by a dry technic, with the patient self-administering much of the treatment. The type of vehicle, nature of the medicaments and method of treatment are too divergent and unrelated to review at this time. Because too few controls have been established, the favorable reports of many preparations have yet to be properly confirmed. Notable exceptions are the reports of Bland and Rakoff1 and Pattyson.2 Consequently, it was deemed wise to observe the therapeutic effect of three arsenical, one silver picrate and two lactose preparations and their respective controls on obstetric
HESSELTINE HC. EVALUATION BY CONTROLLED Series OF VAGINAL TRICHOMONIASIS THERAPIES. JAMA. 1937;109(10):768–771. doi:10.1001/jama.1937.02780360016004
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: